Current strategies and prospects of basic research on prostate cancer immunotherapy

Prostate cancer is one of the common malignant tumors in Chinese men. Most patients are diagnosed with prostate cancer at an advanced stage, and many patients fail to take the best treatment opportunity. The majority of prostate cancer patients progress to castration-resistant prostate cancer after castration, and their alternative treatment options are limited. Immunotherapy has made many breakthroughs in cancer research, and immunotherapy has been proven to bring survival benefits to patients with cancer. However, different types of immunotherapy regimens benefit differently for prostate cancer patients. This article will describe the therapeutic effects of immunotherapy in prostate cancer and its basis research. Key words: Prostate cancer; Immunotherapy